Get started
Author

Iosu Delfrade

Observed names: Delfrade Osinaga, Iosu, Iosu Delfrade Osinaga, Josu Delfrad, Josu Delfrade Osinaga
ORCID: 0000-0002-2331-4542
Observed ORCID: 0000-0002-2331-4542
OpenAlex ID: A5137130890
Breakfast Size and Prevalence of Metabolic Syndrome in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish Cohort
2023 · Leila Lujan-Barroso, Lucia Iglesias, et al. · Nutrients · 8
PDF
Tendencias de la prevalencia de sobrepeso y obesidad infantil en Navarra (2007-2023): un estudio de base poblacional en Atención Primaria
2026 · Edurne Ciriza Barea, Neus Saloni Gómez, et al. · Revista Española de Salud Pública
PDF
Supplementary Figure S1 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Data from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Supplementary Figure S2 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Supplementary Table S4 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Supplementary Figure S4 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Supplementary Table S5 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Supplementary Table S3 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Supplementary Figure S6 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Supplementary Figure S5 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Supplementary Table S2 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Supplementary Figure S3 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Supplementary Table S1 from Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al.
Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression
2026 · Blanca Rius-Sansalvador, Anastasia Chrysovalantou Chatziioannou, et al. · Cancer Epidemiology Biomarkers & Prevention
[Assistance program in quitting tobacco use in Navarra. 25 years on stage].
2019 · Nerea Egüés Olazabal, Iosu Delfrade Osinaga, et al. · PubMed Central
PDF
Works count: 17
Citation count: 8
H-index: 1
I10-index:
Year
Topic
Type